GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Weed BUDZ · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.01

-32.89%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

−$1.4m

FY2016FY2025

Free cash flow

−$195,136

FY2016FY2025

Shareholders' equity

−$688,361

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating income−$1.3m−$529,992−$770,568−$1.4m−$2.8m−$4.1m−$27.4m−$28.4m−$2.4m−$4.1m
Net income−$1.4m−$510,716−$31,557−$1.5m−$2.8m−$4.1m−$27.5m−$29.3m−$3.5m−$4.1m
Diluted earnings per share-0.01-0.00-0.00-0.01-0.02-0.04-0.25-0.28-0.03-0.37

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$559,906$738,366$904,062$1.6m$2.0m$1.8m$2.0m$3.0m$1.3m$5,548
Total liabilities$1.2m$959,372$648,753$1.5m$1.3m$937,278$752,970$259,362$948,128$279,076
Debt——————$391,363———
Shareholders' equity−$688,361−$221,006$255,309$169,796$617,500$881,719$1.2m$2.8m$360,211−$273,528
Shares outstanding147m125m123m123m119m113m109m106m101m11m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$195,136−$415,524−$1.1m−$812,975−$568,914−$430,987−$1.1m−$3.2m−$670,201−$72,776
Capital spending——−$10,000—−$271,233−$271,233−$2,979−$826,481−$826,481−$826,481
Free cash flow−$195,136−$415,524−$1.1m−$812,975−$840,147−$702,220−$1.1m−$4.0m−$1.5m−$899,257

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Operating income−$90,911−$161,157−$726,874−$66,897−$94,045−$434,737−$127,462−$92,649
Net income−$104,132−$175,256−$750,188−$73,946−$107,616−$440,455−$133,224−$95,887
Diluted earnings per share-0.00-0.00-0.01-0.00-0.00-0.00-0.00-0.00
Total assets$504,025$515,713$559,906$532,267$548,906$575,128$738,366$596,818
Shareholders' equity−$939,171−$837,527−$688,361−$519,079−$447,927−$346,236−$221,006−$88,227

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-2.0%-20.1%0.7%
Net income-3.5%-19.5%1.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-1.4-1.4-53.0-1.4-2.1-0.7-0.1-0.4-12.5-0.2

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return289%-63%-20%-66%115%-25%-78%-21%455%1175%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1.015-for-1 split · 29 Dec 2010
  • 1.015-for-1 split · 28 Sept 2010
  • 1.015-for-1 split · 28 Jun 2010
  • 1.015-for-1 split · 29 Mar 2010

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.